FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783246805> ?p ?o ?g. }

• W2783246805 endingPage "e0190272" @default.
• W2783246805 startingPage "e0190272" @default.
• W2783246805 abstract "Background Primaquine (PQ) actively clears mature Plasmodium falciparum gametocytes but in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals can cause hemolysis. We assessed the safety of low-dose PQ in combination with artemether-lumefantrine (AL) or dihydroartemisinin-piperaquine (DP) in G6PDd African males with asymptomatic P. falciparum malaria. Methods and findings In Burkina Faso, G6PDd adult males were randomized to treatment with AL alone (n = 10) or with PQ at 0.25 (n = 20) or 0.40 mg/kg (n = 20) dosage; G6PD-normal males received AL plus 0.25 (n = 10) or 0.40 mg/kg (n = 10) PQ. In The Gambia, G6PDd adult males and boys received DP alone (n = 10) or with 0.25 mg/kg PQ (n = 20); G6PD-normal males received DP plus 0.25 (n = 10) or 0.40 mg/kg (n = 10) PQ. The primary study endpoint was change in hemoglobin concentration during the 28-day follow-up. Cytochrome P-450 isoenzyme 2D6 (CYP2D6) metabolizer status, gametocyte carriage, haptoglobin, lactate dehydrogenase levels and reticulocyte counts were also determined. In Burkina Faso, the mean maximum absolute change in hemoglobin was -2.13 g/dL (95% confidence interval [CI], -2.78, -1.49) in G6PDd individuals randomized to 0.25 PQ mg/kg and -2.29 g/dL (95% CI, -2.79, -1.79) in those receiving 0.40 PQ mg/kg. In The Gambia, the mean maximum absolute change in hemoglobin concentration was -1.83 g/dL (95% CI, -2.19, -1.47) in G6PDd individuals receiving 0.25 PQ mg/kg. After adjustment for baseline concentrations, hemoglobin reductions in G6PDd individuals in Burkina Faso were more pronounced compared to those in G6PD-normal individuals receiving the same PQ doses (P = 0.062 and P = 0.022, respectively). Hemoglobin levels normalized during follow-up. Abnormal haptoglobin and lactate dehydrogenase levels provided additional evidence of mild transient hemolysis post-PQ. Conclusions Single low-dose PQ in combination with AL and DP was associated with mild and transient reductions in hemoglobin. None of the study participants developed moderate or severe anemia; there were no severe adverse events. This indicates that single low-dose PQ is safe in G6PDd African males when used with artemisinin-based combination therapy. Trial registration Clinicaltrials.gov NCT02174900 Clinicaltrials.gov NCT02654730" @default.
• W2783246805 created "2018-01-26" @default.
• W2783246805 creator A5008604633 @default.
• W2783246805 creator A5013139296 @default.
• W2783246805 creator A5018442841 @default.
• W2783246805 creator A5023262714 @default.
• W2783246805 creator A5031912931 @default.
• W2783246805 creator A5033754121 @default.
• W2783246805 creator A5036396443 @default.
• W2783246805 creator A5037076197 @default.
• W2783246805 creator A5040533373 @default.
• W2783246805 creator A5040772126 @default.
• W2783246805 creator A5047851431 @default.
• W2783246805 creator A5051334131 @default.
• W2783246805 creator A5064436714 @default.
• W2783246805 creator A5066290105 @default.
• W2783246805 creator A5067471631 @default.
• W2783246805 creator A5069043533 @default.
• W2783246805 creator A5077345144 @default.
• W2783246805 creator A5080399165 @default.
• W2783246805 date "2018-01-11" @default.
• W2783246805 modified "2023-10-17" @default.
• W2783246805 title "Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials" @default.
• W2783246805 cites W1969834934 @default.
• W2783246805 cites W1985869525 @default.
• W2783246805 cites W1994288452 @default.
• W2783246805 cites W1995078121 @default.
• W2783246805 cites W1998096358 @default.
• W2783246805 cites W2016066083 @default.
• W2783246805 cites W2016759257 @default.
• W2783246805 cites W2021067458 @default.
• W2783246805 cites W2062417163 @default.
• W2783246805 cites W2072894930 @default.
• W2783246805 cites W2088888368 @default.
• W2783246805 cites W2091684277 @default.
• W2783246805 cites W2093298914 @default.
• W2783246805 cites W2101792514 @default.
• W2783246805 cites W2104058573 @default.
• W2783246805 cites W2107918320 @default.
• W2783246805 cites W2114462172 @default.
• W2783246805 cites W2122753628 @default.
• W2783246805 cites W2125583372 @default.
• W2783246805 cites W2130475620 @default.
• W2783246805 cites W2137952006 @default.
• W2783246805 cites W2139477348 @default.
• W2783246805 cites W2140931333 @default.
• W2783246805 cites W2144016867 @default.
• W2783246805 cites W2149236626 @default.
• W2783246805 cites W2152428242 @default.
• W2783246805 cites W2153266724 @default.
• W2783246805 cites W2155009848 @default.
• W2783246805 cites W2155517825 @default.
• W2783246805 cites W2158149195 @default.
• W2783246805 cites W2164191030 @default.
• W2783246805 cites W2165752279 @default.
• W2783246805 cites W2199277501 @default.
• W2783246805 cites W2278941756 @default.
• W2783246805 cites W2294334755 @default.
• W2783246805 cites W2302939988 @default.
• W2783246805 cites W2410532847 @default.
• W2783246805 cites W2416124421 @default.
• W2783246805 cites W2531579561 @default.
• W2783246805 cites W2556688557 @default.
• W2783246805 cites W2793593056 @default.
• W2783246805 cites W4230235846 @default.
• W2783246805 doi "https://doi.org/10.1371/journal.pone.0190272" @default.
• W2783246805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5764271" @default.
• W2783246805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29324864" @default.
• W2783246805 hasPublicationYear "2018" @default.
• W2783246805 type Work @default.
• W2783246805 sameAs 2783246805 @default.
• W2783246805 citedByCount "24" @default.
• W2783246805 countsByYear W27832468052018 @default.
• W2783246805 countsByYear W27832468052019 @default.
• W2783246805 countsByYear W27832468052020 @default.
• W2783246805 countsByYear W27832468052021 @default.
• W2783246805 countsByYear W27832468052022 @default.
• W2783246805 countsByYear W27832468052023 @default.
• W2783246805 crossrefType "journal-article" @default.
• W2783246805 hasAuthorship W2783246805A5008604633 @default.
• W2783246805 hasAuthorship W2783246805A5013139296 @default.
• W2783246805 hasAuthorship W2783246805A5018442841 @default.
• W2783246805 hasAuthorship W2783246805A5023262714 @default.
• W2783246805 hasAuthorship W2783246805A5031912931 @default.
• W2783246805 hasAuthorship W2783246805A5033754121 @default.
• W2783246805 hasAuthorship W2783246805A5036396443 @default.
• W2783246805 hasAuthorship W2783246805A5037076197 @default.
• W2783246805 hasAuthorship W2783246805A5040533373 @default.
• W2783246805 hasAuthorship W2783246805A5040772126 @default.
• W2783246805 hasAuthorship W2783246805A5047851431 @default.
• W2783246805 hasAuthorship W2783246805A5051334131 @default.
• W2783246805 hasAuthorship W2783246805A5064436714 @default.
• W2783246805 hasAuthorship W2783246805A5066290105 @default.
• W2783246805 hasAuthorship W2783246805A5067471631 @default.
• W2783246805 hasAuthorship W2783246805A5069043533 @default.
• W2783246805 hasAuthorship W2783246805A5077345144 @default.
• W2783246805 hasAuthorship W2783246805A5080399165 @default.
• W2783246805 hasBestOaLocation W27832468051 @default.

• next